December 2, 2022

Volume XII, Number 336

Advertisement

December 02, 2022

Subscribe to Latest Legal News and Analysis

December 01, 2022

Subscribe to Latest Legal News and Analysis

November 30, 2022

Subscribe to Latest Legal News and Analysis
Advertisement

WIPO Launches New PCT Patent License Feature

The World Intellectual Property Organization (“WIPO”), which administers the Patent Cooperation Treaty (“PCT”) and processes international PCT patent applications, has announced a new licensing feature that will be available, starting January 1, 2012, to PCT applicants on the WIPO PATENTSCOPE website. The new feature allows applicants to signal their willingness to license inventions contained in their PCT patent applications. 

Applicants can submit a specific PCT form (“Form PCT/IB/382”) entitled “Request for indication of availability for licensing purposes,” or submit a letter indicating that the claimed invention is available for licensing. The submission may also include licensing terms. The licensing indications may be made at any time from the filing of the PCT application until the expiration of the 30-month time period from the application priority date.

Third parties may access the licensing statement via the “Bibliographic data” tab or the “Documents” tab for the particular PCT application on PATENTSCOPE. The licensing statement, however, will not be part of the published international application itself. Additionally, the existence of licensing indications will be added to the list of search criteria within PATENTSCOPE.

©2022 MICHAEL BEST & FRIEDRICH LLPNational Law Review, Volume II, Number 17
Advertisement
Advertisement
Advertisement

About this Author

Teresa Welch, Michael Best Law Firm, Intellectual Property Attorney
Partner

Teresa has more than 20 years of experience procuring patent protection in the area of life sciences, working with clients in the therapeutics and pharmaceutical area in their product life cycles from discovery to development to manufacturing and marketing. She also provides patent strategic advice in regulatory aspects such as Food and Drug Administration Orange Book listing and Hatch-Waxman patent term extension.

Teresa’s clients range from growing pharmaceutical and biotech companies to multi-national companies. She works extensively...

608-283-0108
Gregory J. Hartwig, Michael Best, intellectual property lawyer, patent practice chair
Partner

Clients value Greg’s strategic counsel relating to the protection of their intellectual property assets in the U.S. and abroad. His outstanding track record is built on successful outcomes in high-profile and high-value life sciences and chemical patent matters.

Greg’s extensive background encompasses patent preparation and prosecution, enforcement, and technology dispute resolution, as well as licensing and opinion work in the following technical areas:

  • Therapeutics and small molecules, including orphan...

414-225-4943
Advertisement
Advertisement
Advertisement